Levetiracetam-induced diffuse interstitial lung disease

Scott Newsome, Lanny Y. Xue, Timothy Jennings, Glenn Y. Castaneda

Research output: Contribution to journalArticle

Abstract

The authors report the first case of levetiracetam-induced diffuse interstitial lung disease. The patient is a 9-year-old girl who was admitted to the pediatric intensive care unit for aspiration pneumonia. She has a history of epilepsy, cerebral palsy, mental retardation, asthma, and repeated hospitalizations for presumed aspiration pneumonia, which resolved with conventional medical treatment. She has been on low-dose levetiracetam for her epilepsy over the past 2 years, and the dosage was increased just prior to this admission. However, this time, with conventional treatment, the patient's aspiration pneumonia did not improve, which led to a lung biopsy. The biopsy demonstrated a diffuse interstitial process of relatively recent onset, with features consistent with diffuse lung disease. Levetiracetam was implicated in the pathogenesis of the interstitial pneumonitis. The patient improved clinically after the discontinuation of levetiracetam and with the treatment of steroids.

Original languageEnglish (US)
Pages (from-to)628-630
Number of pages3
JournalJournal of Child Neurology
Volume22
Issue number5
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

etiracetam
Interstitial Lung Diseases
Aspiration Pneumonia
Epilepsy
Biopsy
Pediatric Intensive Care Units
Cerebral Palsy
Intellectual Disability
Lung Diseases
Hospitalization
Therapeutics
Asthma
Steroids
Lung

Keywords

  • Antiepileptic drug
  • Diffuse lung disease
  • Interstitial lung disease
  • Levetiracetam
  • Pneumonia
  • Pneumonitis

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Levetiracetam-induced diffuse interstitial lung disease. / Newsome, Scott; Xue, Lanny Y.; Jennings, Timothy; Castaneda, Glenn Y.

In: Journal of Child Neurology, Vol. 22, No. 5, 05.2007, p. 628-630.

Research output: Contribution to journalArticle

Newsome, Scott ; Xue, Lanny Y. ; Jennings, Timothy ; Castaneda, Glenn Y. / Levetiracetam-induced diffuse interstitial lung disease. In: Journal of Child Neurology. 2007 ; Vol. 22, No. 5. pp. 628-630.
@article{f6e469edfbaa412ab8582f13cb1cdcc9,
title = "Levetiracetam-induced diffuse interstitial lung disease",
abstract = "The authors report the first case of levetiracetam-induced diffuse interstitial lung disease. The patient is a 9-year-old girl who was admitted to the pediatric intensive care unit for aspiration pneumonia. She has a history of epilepsy, cerebral palsy, mental retardation, asthma, and repeated hospitalizations for presumed aspiration pneumonia, which resolved with conventional medical treatment. She has been on low-dose levetiracetam for her epilepsy over the past 2 years, and the dosage was increased just prior to this admission. However, this time, with conventional treatment, the patient's aspiration pneumonia did not improve, which led to a lung biopsy. The biopsy demonstrated a diffuse interstitial process of relatively recent onset, with features consistent with diffuse lung disease. Levetiracetam was implicated in the pathogenesis of the interstitial pneumonitis. The patient improved clinically after the discontinuation of levetiracetam and with the treatment of steroids.",
keywords = "Antiepileptic drug, Diffuse lung disease, Interstitial lung disease, Levetiracetam, Pneumonia, Pneumonitis",
author = "Scott Newsome and Xue, {Lanny Y.} and Timothy Jennings and Castaneda, {Glenn Y.}",
year = "2007",
month = "5",
doi = "10.1177/0883073807302602",
language = "English (US)",
volume = "22",
pages = "628--630",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Levetiracetam-induced diffuse interstitial lung disease

AU - Newsome, Scott

AU - Xue, Lanny Y.

AU - Jennings, Timothy

AU - Castaneda, Glenn Y.

PY - 2007/5

Y1 - 2007/5

N2 - The authors report the first case of levetiracetam-induced diffuse interstitial lung disease. The patient is a 9-year-old girl who was admitted to the pediatric intensive care unit for aspiration pneumonia. She has a history of epilepsy, cerebral palsy, mental retardation, asthma, and repeated hospitalizations for presumed aspiration pneumonia, which resolved with conventional medical treatment. She has been on low-dose levetiracetam for her epilepsy over the past 2 years, and the dosage was increased just prior to this admission. However, this time, with conventional treatment, the patient's aspiration pneumonia did not improve, which led to a lung biopsy. The biopsy demonstrated a diffuse interstitial process of relatively recent onset, with features consistent with diffuse lung disease. Levetiracetam was implicated in the pathogenesis of the interstitial pneumonitis. The patient improved clinically after the discontinuation of levetiracetam and with the treatment of steroids.

AB - The authors report the first case of levetiracetam-induced diffuse interstitial lung disease. The patient is a 9-year-old girl who was admitted to the pediatric intensive care unit for aspiration pneumonia. She has a history of epilepsy, cerebral palsy, mental retardation, asthma, and repeated hospitalizations for presumed aspiration pneumonia, which resolved with conventional medical treatment. She has been on low-dose levetiracetam for her epilepsy over the past 2 years, and the dosage was increased just prior to this admission. However, this time, with conventional treatment, the patient's aspiration pneumonia did not improve, which led to a lung biopsy. The biopsy demonstrated a diffuse interstitial process of relatively recent onset, with features consistent with diffuse lung disease. Levetiracetam was implicated in the pathogenesis of the interstitial pneumonitis. The patient improved clinically after the discontinuation of levetiracetam and with the treatment of steroids.

KW - Antiepileptic drug

KW - Diffuse lung disease

KW - Interstitial lung disease

KW - Levetiracetam

KW - Pneumonia

KW - Pneumonitis

UR - http://www.scopus.com/inward/record.url?scp=34250770050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250770050&partnerID=8YFLogxK

U2 - 10.1177/0883073807302602

DO - 10.1177/0883073807302602

M3 - Article

C2 - 17690072

AN - SCOPUS:34250770050

VL - 22

SP - 628

EP - 630

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 5

ER -